CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Kreatech has signed an agreement with the Lung Cancer Mutation Consortium (LCMC) allowing LCMC study sites to use Kreatech’s Repeat-Free Poseidon fluorescent in situ hybridization (FISH) probes to help identify molecular (DNA) changes in study samples.
Read More »